Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 695 | 2,514 | 372 | 476 | 944 |
| Gross Profit | 695 | 2,514 | 372 | 476 | 944 |
| Operating Expenses | 11,925 | 11,456 | 12,108 | 10,929 | 10,095 |
| Operating Income | -11,230 | -8,942 | -11,736 | -10,453 | -9,151 |
| Interest Expense | 204 | 229 | 232 | 228 | 222 |
| Other Income | 204 | 275 | 339 | 364 | 362 |
| Pre-tax Income | -11,230 | -8,896 | -11,629 | -10,317 | -9,011 |
| Net Income Continuous | -11,230 | -8,896 | -11,629 | -10,317 | -9,011 |
| Net Income | $-11,230 | $-8,896 | $-11,629 | $-10,317 | $-9,011 |
| EPS Basic Total Ops | -5.40 | -4.35 | -5.70 | -5.10 | -4.35 |
| EPS Basic Continuous Ops | -5.42 | -4.30 | -5.64 | -5.22 | -4.40 |
| EPS Diluted Total Ops | -5.40 | -4.35 | -5.70 | -5.10 | -4.35 |
| EPS Diluted Continuous Ops | -5.42 | -4.30 | -5.64 | -5.22 | -4.40 |
| EBITDA(a) | $-11,569 | $-8,689 | $-11,845 | $-10,565 | $-9,251 |